Fred Kurland

This profile gathers the share dealings of Fred Kurland across 2 companies, led by XOMA Royalty Corp and Aridis Pharmaceuticals, Inc. In total, 32 filings cover trades dated from 25 March 2011 to 5 June 2023.

The open-market side counts 1 purchase for €12k alongside 6 sales for €164k. On balance, insiders were net sellers of €152k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants and 11 option exercises.

The newest entry dates from 15 June 2023: an option exercise, in Aridis Pharmaceuticals, Inc. The last purchase on record was published on 28 March 2011, which is 5,704 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.